Old TB vaccine may work better when delivered intravenously
Delivering the only approved tuberculosis vaccine intravenously greatly enhanced its ability to protect rhesus monkeys from infection. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - January 13, 2020 Category: Consumer Health News Source Type: news
Bharat Biotech keen to revive Rs 600 crore TN vaccine complex
With a planned annual capacity of 585 million, the project proposed to make pentavalent, or five-in-one, combination vaccine, BCG vaccine, and vaccines to prevent measles, hepatitis B, human rabies, Hib (haemophilus influenzae type b) and Japanese encephalitis (JE) in the first phase, which was to be commissioned by 2010. (Source: The Economic Times)
Source: The Economic Times - January 2, 2020 Category: Consumer Health News Source Type: news
TB Vaccine More Powerful When Given Intravenously
THURSDAY, Jan. 2, 2020 -- The tuberculosis (TB) vaccine is far from infallible, but new animal research suggests the problem is not the vaccine but how it is delivered.
When given to monkeys intravenously rather than as an injection, the vaccine... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 2, 2020 Category: General Medicine Source Type: news
Injecting TB vaccine straight into bloodstream makes the 100-year-old shot far more effective
A new study from the National Institutes of Health has found that administering the tuberculosis vaccine straight into the vein was more effective than the shot injected into the skin. (Source: the Mail online | Health)
Source: the Mail online | Health - January 2, 2020 Category: Consumer Health News Source Type: news
New Injection Method Makes an Old TB Vaccine Far More Powerful
Giving the vaccine intravenously to monkeys provided 90% protection against tuberculosis. More testing is needed before humans can be inoculated that way. (Source: NYT)
Source: NYT - January 1, 2020 Category: American Health Authors: Donald G. McNeil Jr. Tags: Tuberculosis Vaccination and Immunization Monkeys and Apes Lungs Third World and Developing Countries National Institute of Allergy and Infectious Diseases University of Pittsburgh Nature (Journal) Seder, Robert A Africa your-feed-heal Source Type: news
Changed route of immunization dramatically improves efficacy of TB vaccine
(NIH/National Institute of Allergy and Infectious Diseases) Tuberculosis (TB), an ancient disease, is the leading infectious cause of death globally, yet the world's only licensed TB vaccine, Bacille Calmette-Guerin (BCG), was developed a century ago. Given to infants via a needle placed just under the skin, BCG protects babies from a form of the disease called disseminated TB but is far less effective at preventing pulmonary TB, the major cause of illness and deaths, in teens or adults. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 1, 2020 Category: Infectious Diseases Source Type: news
Delivering TB vaccine intravenously dramatically improves potency, study shows
(University of Pittsburgh) Worldwide, more people die from tuberculosis than any other infectious disease, even though the vast majority were vaccinated. The vaccine just isn't that reliable. But a new Nature study finds that simply changing the way the vaccine is administered could dramatically boost its protective power. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 1, 2020 Category: Infectious Diseases Source Type: news
Changed route of immunization dramatically improves efficacy of TB vaccine
NIH scientists report results from animal study. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 31, 2019 Category: American Health Source Type: news
Home for the holidays -- But will grandpa remember me?
(The Hebrew University of Jerusalem) Home for the Holidays - But Will Grandpa Remember Me?Now there's Hope; Hebrew University Team Finds TB Vaccine Lowers Rates of Alzheimer's Disease in Cancer Patients (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 23, 2019 Category: Cancer & Oncology Source Type: news
Research Nonprofit Shutters TB Vaccine Effort and Lays Off Scientists
A financially troubled Seattle research institute cut back programs, leaving researchers to find new homes for work on infectious diseases like tuberculosis and leprosy. (Source: NYT Health)
Source: NYT Health - December 14, 2019 Category: Consumer Health News Authors: Katie Thomas Tags: Infectious Disease Research Institute Vaccination and Immunization Tuberculosis Nonprofit Organizations Drugs (Pharmaceuticals) Leprosy (Hansen ' s Disease) Leishmaniasis Layoffs and Job Reductions Seattle (Wash) your-feed-healthcare Source Type: news
A Research Nonprofit Shutters TB Vaccine Effort and Lays Off Scientists
A financially troubled Seattle research institute cut back programs, leaving researchers to find new homes for work on infectious diseases like tuberculosis and leprosy. (Source: NYT Health)
Source: NYT Health - December 13, 2019 Category: Consumer Health News Authors: Katie Thomas Tags: Infectious Disease Research Institute Vaccination and Immunization Tuberculosis Philanthropy Nonprofit Organizations Drugs (Pharmaceuticals) Leprosy (Hansen ' s Disease) Leishmaniasis Layoffs and Job Reductions Seattle (Wash) your- Source Type: news
Common TB Vaccine Associated With Lower Lung Cancer Rates
In 60 - year follow - up, significantly lower lung cancer rates seen for those with childhood BCG vaccination (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 18, 2019 Category: Cancer & Oncology Tags: Family Medicine, Infections, Internal Medicine, Oncology, Pathology, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news
Common TB Vaccine Associated With Lower Lung Cancer Rates
MONDAY, Nov. 18, 2019 -- Childhood vaccination with the bacille Calmette-Gu érin (BCG) vaccine is associated with a reduced risk for lung cancer, according to a study published online Sept. 25 in JAMA Network Open.
Nicholas T. Usher, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2019 Category: Pharmaceuticals Source Type: news
CSU lands $1.2 million in NIH funding to advance work on a new tuberculosis vaccine
(Colorado State University) The research led by assistant professors Marcela Henao-Tamayo and Brendan Podell is part of a $44.8 million, seven-year award to the Infectious Disease Research Institute, based in Seattle. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 15, 2019 Category: Infectious Diseases Source Type: news
Experimental TB Vaccine Partially Effective: Study
Tested in patients with the latent form of tuberculosis, the vaccine prevented the development of the active form of infection in 50 percent more individuals compared with unvaccinated patients. (Source: The Scientist)
Source: The Scientist - October 30, 2019 Category: Science Tags: News & Opinion Source Type: news
